Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis
Condition(s) studied
Investigational drug(s) / intervention(s)
Supportive periodontal and periimplant care: Periodontal and peri-implant maintenance therapy will be carried out at baseline, 3 and 6-month visit. This session will include the removal of biofilm and calculus on teeth and implants (except those that have just been restored) with an ultrasonic device using a plastic tip ( for implants. and a conventional metal tip ( for teeth. At the end, polishing will be done with a rubber cup Subsequently, patients will be explained that they must continue with their usual oral hygiene technique on their teeth, using the same type of brush (which can be electric or manual), interproximal devices, toothpaste or mouthwash used to date. Finally, they will receive specific instructions for the supragingival biofilm control in the area of the new restoration and will be given interdental brushes that suit to the space
Study summary
the objective of this study is to determine the incidence of peri-implant mucositis in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. An analytical prospective observational study will be carried out, with an initial follow-up of 12 months.
Eligibility
Primary outcome measure(s)
- Incidence of peri-implant mucositis — 12 months
The risk of developing PM (patient with at least one implant who has bleeding on probing, with or without suppuration and without progressive radiographic bone loss) during a follow-up period of 12 months.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Faculty of Dentistry, University Complutense of Madrid (UCM) | Madrid | Spain | Recruiting |
More Universidad Complutense de Madrid trials in Spain
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05356806 on ClinicalTrials.gov ↗ ← All trials in Spain